---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-102321"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:50:26.351567+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics receives Nasdaq delisting notice for failing to meet $1.00 bid price rule

## Summary
- Nasdaq notified MiNK on Aug 27, 2024 that it failed to regain compliance with the $1.00 minimum bid price within the 180-day grace period ending Aug 26, 2024.
- Common stock (INKT) is now subject to potential delisting from Nasdaq.
- MiNK intends to request a hearing before the Nasdaq Hearings Panel, which will stay any delisting action pending the process.
- No assurance that the Panel will allow continued listing or that compliance can be demonstrated within any extension granted.

## SEC filing metadata
- accession: 0000950170-24-102321
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017024102321/0000950170-24-102321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017024102321/inkt-20240827.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-102321
- JSON: https://secwatch.observer/filing/0000950170-24-102321.json
- Plain text: https://secwatch.observer/filing/0000950170-24-102321.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.